Guardant Health Shield Blood Test Demonstrates Leading Screening Adherence and CRC Deaths Averted Compared to Stool-Based Tests
Guardant Health Announces Approval in Europe of Guardant360® CDx as Companion Diagnostic for AstraZeneca's ETCAMAH in Advanced ER-positive Breast Cancer
Guardant Health COSMOS Study Published in Cancer Research Communications Validates Utility of Guardant Reveal Liquid Biopsy Test for Predicting Recurrence in Melanoma
Guardant Health COSMOS Study Published in Cancer Research Communications Validates Utility of Guardant Reveal Liquid Biopsy Test for Predicting Recurrence in Melanoma
Guardant Health and Collaborators to Present 20 Abstracts Highlighting Portfolio of Liquid Biopsy Tests for Early Detection and Ongoing Treatment Management at 2026 World Conference on Lung Cancer
Guardant Health's Shield Blood Test Covered by Carelon Health Services for Colorectal Cancer Screening
Premier American Uranium Completes US$5 Million Strategic Equity Investment by DISA Uranium; IsoEnergy Increases its Strategic Holding
